Evaluating the Symptom and Disease-Modifying Effects of 2.5% Intra-Articular Polyacrylamide Hydrogel in the Equine Osteochondral Fragment Model for Osteoarthritis

Wednesday, December 10, 2025

9:00 AM - 9:20 AM MT